The Telegraph6m
People 50 and older should get pneumococcal vaccine, U.S. health officials recommend
U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can cause pneumonia ...
Israel kicks off new COVID vaccine campaign targeting JN1 variant: What you need to know
The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.
Pfizer: CDC Advisory Committee expands recommendation for use of Prevnar 20
Pfizer (PFE) announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice voted to ...
CDC Panel Backs Expanded Use Of Pfizer's Pneumococcal Vaccine
Pfizer Inc. (PFE) announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization ...
US CDC advisers recommend expanding pneumococcal vaccine to adults aged 50-64
The CDC currently recommends all children younger than 5 and all adults 65 years or older get vaccinated for the disease. The ...
WZZM5h
Experts encourage pregnant women to get the RSV vaccine before cases begin to rise
Right now, the only RSV vaccine pregnant people can get is the Pfizer vaccine. But there are other vaccines you can get for ...
FiercePharma8h
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
ENDPOINTS NEWS10h
Pfiz­er wins ap­proval to ex­pand RSV vac­cine to adults at high­er in­fec­tion risk
Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...
BioSpace16h
Pfizer Wins FDA Approval of RSV Vaccine for Broader Adult Population
Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.